4B2

(4S)-4-[2,4-difluoro-5-(pyrimidin-5-yl)phenyl]-4-methyl-5,6-dihydro-4H-1,3-thiazin-2-amine

Created:	2015-02-23
Last modified:	2020-06-05

Find Related PDB Entry
1 entries where 4B2 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	36
Chiral Atom Count	1
Bond Count	38
Aromatic Bond Count	12

2D diagram of 4B2

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(4S)-4-[2,4-difluoro-5-(pyrimidin-5-yl)phenyl]-4-methyl-5,6-dihydro-4H-1,3-thiazin-2-amine
Synonyms	LY2811376; BACE inhibitor
Systematic Name (OpenEye OEToolkits)	(4S)-4-[2,4-bis(fluoranyl)-5-pyrimidin-5-yl-phenyl]-4-methyl-5,6-dihydro-1,3-thiazin-2-amine
Formula	C₁₅ H₁₄ F₂ N₄ S
Molecular Weight	320.36
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	Fc2c(c1cncnc1)cc(c(F)c2)C3(N=C(SCC3)N)C
SMILES	CACTVS	3.385	C[C]1(CCSC(=N1)N)c2cc(c(F)cc2F)c3cncnc3
SMILES	OpenEye OEToolkits	1.9.2	CC1(CCSC(=N1)N)c2cc(c(cc2F)F)c3cncnc3
Canonical SMILES	CACTVS	3.385	C[C@]1(CCSC(=N1)N)c2cc(c(F)cc2F)c3cncnc3
Canonical SMILES	OpenEye OEToolkits	1.9.2	C[C@]1(CCSC(=N1)N)c2cc(c(cc2F)F)c3cncnc3
InChI	InChI	1.03	InChI=1S/C15H14F2N4S/c1-15(2-3-22-14(18)21-15)11-4-10(12(16)5-13(11)17)9-6-19-8-20-7-9/h4-8H,2-3H2,1H3,(H2,18,21)/t15-/m0/s1
InChIKey	InChI	1.03	MJQMRGWYPNIERM-HNNXBMFYSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB13065
Name	LY-2811376
Groups	investigational
Description	LY2811376 has been used in trials studying the basic science of Alzheimer's Disease.
Synonyms	LY-2811376
Categories	Sulfur Compounds
CAS number	1194044-20-6

Related Resource References

Resource Name	Reference
Pharos	CHEMBL2333941
PubChem	44251605
ChEMBL	CHEMBL2333941

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.